“…Specifically, the enzyme positively regulates activation of macrophages (8,9,35), microglia (7,36), granulocytes (37), lymphocytes (6,13,14), as well as TNF-␣-challenged endothelial cells (38). Also, parp-1 null mice are resistant to endotoxic shock (39), and PARP-1 inhibitors provide protection in models of pleuritis (40), arthritis (41), asthma (42), colitis (43,44), allergic encephalomyelitis (6,15,45), and other autoimmune disorders (46).…”